In Vitro Models for Drug Development in Diabetes
Johnna Wesley,
Vice President, Global Drug Discovery for T1D & CKD,
Novo Nordisk
The presentation will discuss improving disease model systems and using human data to guide the in vitro assay development to aid drug development. This includes a discussion of 3D islet-immune model and relevance to human Type 1 diabetes.
|
|
